
Iran eases pharmaceutical import regulations to boost medicine supply
Iran's Food and Drug Administration has temporarily relaxed GMP requirements for foreign drug manufacturers to accelerate the import of essential medicines and raw materials.
Background
Iran faces ongoing challenges in ensuring a consistent supply of essential medicines, often due to international sanctions impacting trade and financial transactions. The government frequently seeks measures to mitigate these shortages and maintain public health services for its population.
Quorum · collective opinions
Iran's Pharmaceutical Import Regulations Eased
First report 1h agoLast update 1h agoTemporary easing of GMP requirements for foreign drug producers aims to speed up the supply of essential medicines and raw materials into the country.
iWitness comments
No comments yet — be the first to weigh in.